New York State Teachers Retirement System Has $69.43 Million Stock Holdings in HCA Healthcare, Inc. $HCA

New York State Teachers Retirement System decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 146,712 shares of the company’s stock after selling 2,995 shares during the period. New York State Teachers Retirement System owned 0.07% of HCA Healthcare worth $69,430,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in HCA. Private Advisor Group LLC lifted its stake in HCA Healthcare by 4.0% in the first quarter. Private Advisor Group LLC now owns 5,993 shares of the company’s stock valued at $2,836,000 after acquiring an additional 229 shares during the last quarter. Optas LLC raised its holdings in shares of HCA Healthcare by 15.5% during the 1st quarter. Optas LLC now owns 1,160 shares of the company’s stock valued at $549,000 after purchasing an additional 156 shares in the last quarter. Y Intercept Hong Kong Ltd increased its position in HCA Healthcare by 66.9% during the first quarter. Y Intercept Hong Kong Ltd now owns 13,667 shares of the company’s stock worth $6,468,000 after buying an additional 5,477 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in shares of HCA Healthcare by 59.0% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 67,539 shares of the company’s stock worth $31,962,000 after buying an additional 25,070 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC increased its holdings in shares of HCA Healthcare by 217.8% during the 1st quarter. Elevation Point Wealth Partners LLC now owns 21,202 shares of the company’s stock valued at $10,034,000 after acquiring an additional 14,530 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $409.99 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a market capitalization of $90.95 billion, a P/E ratio of 14.10, a P/E/G ratio of 1.25 and a beta of 1.12. The firm’s fifty day moving average price is $401.89 and its two-hundred day moving average price is $462.80.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Royal Bank Of Canada reduced their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Leerink Partners dropped their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Sanford C. Bernstein decreased their price target on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a report on Thursday, June 4th. Finally, Barclays cut their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $503.00.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.